QYUNS-B(02509.HK)

Last Updated 08:00:00
longbridge loading

JPM: NRDL Adjustment to Accelerate Commercialization of Innovative Drugs; Top Picks INNOVENT BIO , WUXI APPTEC , WUXI XDC , SKB BIO

AASTOCKS News·
HK
02509
-2.14%
SH
603259
-0.25%
US
WXXWY
+0.05%
AASTOCKS News·
HK
02509
-2.14%
SH
603259
-0.25%
US
WXXWY
+0.05%

Top 10 HK Stock Losers (4.23)

Top Gainers&Losers·
HK
00068
-4.34%
HK
02655
-2.13%
HK
02635
+0.17%
Top Gainers&Losers·
HK
00068
-4.34%
HK
02655
-2.13%
HK
02635
+0.17%

Top 10 HK Stock Gainers (4.15)

Top Gainers&Losers·
HK
02442
-0.84%
HK
06651
-6.18%
HK
09606
-3.32%
Top Gainers&Losers·
HK
02442
-0.84%
HK
06651
-6.18%
HK
09606
-3.32%

Qyuns Therapeutics Co., Ltd. Class H (2509) Gets a Buy from CICC

Tip Ranks·
SH
513120
+0.18%
HK
02509
-2.14%
SZ
159615
+0.10%
Tip Ranks·
SH
513120
+0.18%
HK
02509
-2.14%
SZ
159615
+0.10%

"Performance" QYUNS's annual net profit is 314 million RMB, turning losses into profits

AASTOCKS·
SZ
159102
+0.27%
SZ
159837
0.00%
SZ
159849
+0.21%
AASTOCKS·
SZ
159102
+0.27%
SZ
159837
0.00%
SZ
159849
+0.21%

Top 10 HK Stock Losers (2.26)

Top Gainers&Losers·
HK
00881
+0.15%
HK
02865
-4.21%
HK
03931
-1.75%
Top Gainers&Losers·
HK
00881
+0.15%
HK
02865
-4.21%
HK
03931
-1.75%

The Hang Seng Biotechnology Index rose over 4% intraday, CSPC PHARMA rose over 7%, INNOVENT BIO rose nearly 7%, WUXI BIO and SINO BIOPHARM rose over 5%

Wallstreetcn·
HK
01093
-1.72%
HK
01801
-0.37%
HK
02269
+0.18%
Wallstreetcn·
HK
01093
-1.72%
HK
01801
-0.37%
HK
02269
+0.18%

Qyuns Therapeutics Launches Share Buyback as Board Deems Stock Undervalued

Tip Ranks·
HK
02509
-2.14%
Tip Ranks·
HK
02509
-2.14%

Top 10 HK Stock Losers (1.23)

Top Gainers&Losers·
HK
01757
-0.12%
HK
06681
+34.43%
HK
00917
+2.28%
Top Gainers&Losers·
HK
01757
-0.12%
HK
06681
+34.43%
HK
00917
+2.28%

Understanding the Market | QYUNS-B rose over 11% during the session, its QX031N licensed to Roche; institutions say this transaction has certain rarity

Zhitong·
HK
02509
-2.14%
Zhitong·
HK
02509
-2.14%
© 2026 Longbridge｜Disclaimer